Symyx Technologies Inc

Symyx Technologies — Merger or Acquisition (May 2010)

24 slides from Symyx Technologies's merger presentation, May 6, 2010

  1. Slide 1: Filed by Accelrys, Inc. Pursuant to Rule 425

    Filed by Accelrys, Inc. Pursuant to Rule 425 under the Securities Act of 1933 (the “Securities Act”) and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 (the “Exchange Act”) Securities Act File No.: 333-166524 Subject Company: Symyx Technologies, Inc. Exchange Act File

  2. Slide 2: Accelrys, Inc. Investor Presentation May 2010

    Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO

  3. Slide 3: Safe Harbor Information

    Safe Harbor Information Safe Harbor Provisions When used in this presentation, words such as expects, believes,anticipates, estimates, and similar expressionsidentify forward- looking statements. Forward-lookingstatements may includestatements relating to our growth strategy, the future size of our

  4. Slide 4: Investment Summary

    Investment Summary • Creates the leading enterprise scientific informatics software company • Provides the unparalleled capability of managing end-to-end scientific workflows to achieve better outcomes • Deep expertise in chemistry, biology and materials science creates a sustainable competitive adv

  5. Slide 5: Market Environment

    GRaccelrys’ Market Environment

  6. Slide 6: Scientific R&D Challenges

    Scientific R&D Challenges Balance Innovation, Automation, Collaboration The economics of innovation - as R&D is done today – are unsustainable. If companies are to overcome these obstacles they will need to establish processes and structures that promote innovation… The Enterprise of the Future IBM

  7. Slide 7: Today's Research & Development Challenge

    Today’s Research & Development Challenge Drive Top Line Growth More Innovation Drive Increased Profitability • Increase R&D Success Rate – Re-Use Corporate Knowledge – Improve Data Modeling and Simulations Better Productivity – Increase Time Available for • Increase R&D Efficiency Experiments – Redu

  8. Slide 8: Merger with Symyx

    GRaccelrys’ Merger with Symyx

  9. Slide 9: Combining Industry Leaders

    Combining Industry Leaders Founded:2001 Founded:1996 Public: ACCL (NASDAQ) Public:SMMX (NASDAQ) FY 2009 Revenue: $80.9M CY 2009 Revenue: $88.6M* Leading positions in: Leading positions in: Data Collection and Analysis Electronic Laboratory Notebook Data Access, Integration & Transformation Decision

  10. Slide 10: Industry Leading Scientific Informatics Platform

    Industry Leading Scientific Informatics Platform Head of IT & Scientists R&D Manager VP of R&D Informatics Scientific Desktop Decision Support Analytics Reporting, Visualization & Collaboration Workflow Automation Scientific Information Management 9

  11. Slide 11: With Global Brand Customer Portfolio and Minimal Product Overlap

    With Global Brand Customer Portfolio and Minimal Product Overlap Accelrys+ Symyx has over 1,350 total, unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5 aerospace companies • 3 of the top 5 CPG companies • And major Governm

  12. Slide 12: Vibrant & Growing Partner Ecosystem

    Vibrant & Growing Partner Ecosystem Additional applications and solutions developed by partner community More choice for customers in implementing successful deployments Scientific Informatics Software System Electronic Lab Notebook Decision Support And Analytics Reporting, Visualization And Collabo

  13. Slide 13: Revenue Growth Drivers

    GRaccelrys’ Revenue Growth Drivers

  14. Slide 14: Revenue Growth Drivers

    Revenue Growth Drivers • New scientific markets • Biology/BioReg • Professional Services • Scientific Informatics Platform - Pipeline Pilot 8.0 • ELN –Symyx Notebook 6.4 • ELN/Pipeline Pilot integrations 13

  15. Slide 15: Pipeline Pilot

    Pipeline Pilot • Enterprise Scientific Data Pipelining Platform • Data collection and Integration • Analysis • Visualization • Application Deployment • Capabilities • Integration of diverse data and applications • Automated scientific data analysis and processing • Capture and deployment of best-pra

  16. Slide 16: ELN/ELE

    ELN/ELE Symyxholds #2 overall market position with15% share. Positionedto growshareandestablishoverallmarketleadership– through aggressive internal development and partnering strategy 2010 Symyx Market Position by Domain No. 1 Market Position No. 2 or 3 Market Position DMPK* Market Position 50% *Add

  17. Slide 17: Deal Terms & Financials

    GRaccelrys’ Deal Terms & Financials

  18. Slide 18: Terms of Deal

    Terms of Deal Merger Agreement Tax-free, all stock merger of equals Closing Expected to close early in September quarter Exchange Ratio 0.7802 Ownership Each company’s stockholders will own approximately 50% of combined company Market Capitalization Combined market cap of ~ $335M (pre-announcement)

  19. Slide 19: Proforma Balance Sheet

    Proforma Balance Sheet December 31, 2009 ($ in thousands) Current Assets Cash & cash equivalents $ 133,841 Marketable securities 11,607 Restricted cash 780 Trade receivables 38,972 Other current assets 22,765 207,965 Restricted cash 5,560 Property & equipment 11,256 Goodwill & intangibles 140,016 Ot

  20. Slide 20: Proforma Income Statement

    Proforma Income Statement 9 Months Ended December 31, 2009 ($ in thousands) Historical Pro Forma Pro Forma Accelrys Symyx Adjustments Combined Revenue 62,200 66,858 - 129,058 Cost of revenue 10,896 19,821 (3,771) 26,946 Gross margin 51,304 47,037 3,771 102,112 Operating expenses Product development

  21. Slide 21: Key Dates

    Key Dates Event Expected Timeline SMMX Q1 earnings release 4/29 Filing of joint proxy statement 5/5 HSR clearance ~5/12 ACCL Board Meeting 5/18-19 ACCL Q4/YE earnings release 5/20 SEC clearance ~6/5 Shareholder’s Meetings (ACCL & SMMX) 7/19 Closing 7/20 Continuous Integration Planning Activities 20

  22. Slide 22: Investment Summary

    Investment Summary • Creates the leading enterprise scientific informatics software company • Provides the unparalleled capability of managing end-to-end scientific workflows to achieve better outcomes • Deep expertise in chemistry, biology and materials science creates a sustainable competitive adv

  23. Slide 23: Accelrys, Inc. Investor Presentation

    Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO

  24. Slide 24: Forward-Looking Statements

    Forward-Looking Statements Certain statements in this communication may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to a variety of matters, including but not limited to: the timing and anticipated complet

Symyx Technologies — Merger or Acquisition (May 2010) on 6ix